Overview Money In Money Out People Connected Orgs Positions Interview Endorsements
About We unite, lead, and grow the endocrine community to accelerate scientific breakthroughs and improve health worldwide.
Donations are tax-deductible
Financial Snapshot FY ending 2024-12-31 Financial history 16 17 18 19 20 21 22 23 24
Latest FY2024: $27.3M · Peak FY2016: $33.5M · Avg: $29.2M
Foreign activity (Schedule F) Total spent abroad $40K
Foreign employees 0
Foreign offices 0
Foreign partnership interest No
Foreign trust interest No
Region Activity Spent EAST ASIA & THE PACIFIC — — EUROPE (INCLUDING ICELAND & GREENLAND) — — MIDDLE EAST AND NORTH AFRICA — — NORTH AMERICA (WHICH INCLUDES CANADA AND MEXICO, BUT NOT THE U.S.) — — SOUTH AMERICA — — SOUTH AMERICA — — SUB-SAHARAN AFRICA — —
501(h) election This 501(c)(3) elected the 501(h) safe-harbor — lobbying expenditures are capped under a clear dollar formula instead of the "insubstantial part" standard.
Political & Grant Activity Address 2055 L ST NW STE 600
Washington, DC, 20036-498
Governance Voting board members 16
Independent members 12
Conflict-of-interest policy Yes
Whistleblower policy Yes
Doc-retention policy Yes
Audit committee Yes
990 reviewed by board Yes
Compensation practices Severance payments No
Equity-based comp No
Supplemental retirement plan No
Compensation committee Yes
Used comp survey Yes
Board approved comp Yes
Initial contract exception No
Financial detail (Schedule D) Board-designated % 0.0%
Permanent endowment % 59.6%
Endowment held by related org No
Public records
These open in a new tab. AllCiv doesn't host filings directly — these are the authoritative public-record sources.